InvestorsHub Logo
Followers 13
Posts 727
Boards Moderated 0
Alias Born 06/17/2014

Re: exwannabe post# 585488

Friday, 04/14/2023 3:31:43 PM

Friday, April 14, 2023 3:31:43 PM

Post# of 730111

They tried to get approved based on a P2 that failed the primary endpoint of PFS but was stat sig on the secondary endpoint of OS. The FDA said that is no good and they needed a real P3 trial that properly defined the prospective OS endpoint in advance.



I think there have been a few changes in FDA's thinking since 2009.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News